University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Thomas Vail

Thomas Vail, M.D.

Chair of Orthopedic Surgery

Dr. Thomas Parker Vail, chair of Orthopedic Surgery at UCSF, is a specialist in total joint replacement and preservation of the hip and knee and surgical treatment of arthritis and osteonecrosis. In his research, Vail focuses on innovative bone implant techniques, clinical outcomes of devices used in adult reconstruction and repair of cartilage.

As chair of Orthopedic Surgery, Vail oversees the department's clinical, research and education activities.

Read a Q&A with Vail.

Clinics

Arthritis and Joint Replacement Center
1500 Owens St.
San Francisco, CA 94158
Phone: (415) 353–2808
Fax: (415) 885–3862

Hours: Monday to Friday, 8 a.m. – 5 p.m.

Conditions & Treatments

  • Hip Arthroscopy
  • Hip Resurfacing

More about Thomas Vail

Additional Languages

Spanish

Education

Loyola University School of Medicine 1985

Residencies

Duke University, Orthopaedic Surgery 1991

Fellowships

Duke University, Reconstructive/Cosmetic Surgery 1992

Selected Research and Publications

  1. Lockhart PB, Garvin KL, Osmon DR, Hewlett AL, Scuderi G, Lewallen D, Vail T. The antibiotic prophylaxis guideline for prosthetic joints: trying to do the right thing. J Am Acad Orthop Surg. 2013 Mar; 21(3):193-4.
  2. Barnes CL, Vail TP, Takemoto SK. Where do knee revisions for infection, fracture, and other revisions get treated? J Arthroplasty. 2013 Mar; 28(3):423-8.
  3. Hug KT, Watters TS, Vail TP, Bolognesi MP. The Withdrawn ASR™ THA and Hip Resurfacing Systems: How Have Our Patients Fared Over 1 to 6 Years? Clin Orthop Relat Res. 2013 Feb; 471(2):430-8.
  4. Hug KT, Watters TS, Vail TP, Bolognesi MP. Reply to Letter to the Editor: The Withdrawn ASR™ THA and Hip Resurfacing Systems: How Have Our Patients Fared Over 1 to 6 Years? Clin Orthop Relat Res. 2013 Jan; 471(1):337.
  5. Bozic KJ, Ong K, Lau E, Berry DJ, Vail TP, Kurtz SM, Rubash HE. Estimating Risk in Medicare Patients With THA: An Electronic Risk Calculator for Periprosthetic Joint Infection and Mortality. Clin Orthop Relat Res. 2013 Feb; 471(2):574-83.
  6. Queen RM, Newman ET, Abbey AN, Vail TP, Bolognesi MP. Stair ascending and descending in hip resurfacing and large head total hip arthroplasty patients. J Arthroplasty. 2013 Apr; 28(4):684-9.
  7. Bozic KJ, Lau EC, Ong KL, Vail TP, Rubash HE, Berry DJ. Comparative effectiveness of metal-on-metal and metal-on-polyethylene bearings in medicare total hip arthroplasty patients. J Arthroplasty. 2012 Sep; 27(8 Suppl):37-40.
  8. Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am. 2012 May 2; 94(9):794-800.
  9. Worni M, Pietrobon R, Zammar GR, Shah J, Yoo B, Maldonato M, Takemoto S, Vail TP. System dynamics to model the unintended consequences of denying payment for venous thromboembolism after total knee arthroplasty. PLoS One. 2012; 7(4):e30578.
  10. Flink BJ, Rivelli SK, Cox EA, White WD, Falcone G, Vail TP, Young CC, Bolognesi MP, Krystal AD, Trzepacz PT, Moon RE, Kwatra MM. Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly. Anesthesiology. 2012 Apr; 116(4):788-96.
  11. Viens NA, Hug KT, Marchant MH, Cook C, Vail TP, Bolognesi MP. Role of diabetes type in perioperative outcomes after hip and knee arthroplasty in the United States. J Surg Orthop Adv. 2012; 21(4):253-60.
  12. Lachiewicz PF, Bolognesi MP, Henderson RA, Soileau ES, Vail TP. Can tantalum cones provide fixation in complex revision knee arthroplasty? Clin Orthop Relat Res. 2012 Jan; 470(1):199-204.
  13. Cooke ME, Allon AA, Cheng T, Kuo AC, Kim HT, Vail TP, Marcucio RS, Schneider RA, Lotz JC, Alliston T. Structured three-dimensional co-culture of mesenchymal stem cells with chondrocytes promotes chondrogenic differentiation without hypertrophy. Osteoarthritis Cartilage. 2011 Oct; 19(10):1210-8.
  14. Giaconi JC, Link TM, Vail TP, Fisher Z, Hong R, Singh R, Steinbach LS. Morbidity of direct MR arthrography. AJR Am J Roentgenol. 2011 Apr; 196(4):868-74.
  15. Vail TP. Hip resurfacing. J Am Acad Orthop Surg. 2011 Apr; 19(4):236-44.
  16. Goldberg VM, Buckwalter J, Halpin M, Jiranek W, Mihalko W, Pinzur M, Rohan B, Vail T, Walker P, Windsor R, Wright T. Recommendations of the OARSI FDA Osteoarthritis Devices Working Group. Osteoarthritis Cartilage. 2011 May; 19(5):509-14.
  17. Vail TP. Commentary on an article by Joseph F. Styron, PhD, et al.: "Preoperative predictors of returning to work following primary total knee arthroplasty". J Bone Joint Surg Am. 2011 Jan 5; 93(1):e2.
  18. Bozic KJ, Maselli J, Pekow PS, Lindenauer PK, Vail TP, Auerbach AD. The influence of procedure volumes and standardization of care on quality and efficiency in total joint replacement surgery. J Bone Joint Surg Am. 2010 Nov 17; 92(16):2643-52.
  19. Queen RM, Watters TS, Abbey AN, Sabesan VJ, Vail TP, Bolognesi MP. Gait symmetry: a comparison of hip resurfacing and jumbo head total hip arthroplasty patients. J Arthroplasty. 2011 Aug; 26(5):680-5.
  20. Bozic KJ, Ong K, Lau E, Kurtz SM, Vail TP, Rubash HE, Berry DJ. Risk of complication and revision total hip arthroplasty among Medicare patients with different bearing surfaces. Clin Orthop Relat Res. 2010 Sep; 468(9):2357-62.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California